Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a report published on Tuesday. The firm issued a hold rating on the stock.

Retractable Technologies Stock Up 2.9 %

Shares of RVP opened at $0.59 on Tuesday. The company has a market cap of $17.60 million, a PE ratio of -1.06 and a beta of 2.06. The business has a fifty day moving average of $0.76 and a 200 day moving average of $0.96. Retractable Technologies has a 52-week low of $0.56 and a 52-week high of $1.34. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01.

Insider Buying and Selling

In other Retractable Technologies news, CEO Thomas J. Shaw bought 71,422 shares of the firm’s stock in a transaction dated Friday, September 20th. The stock was acquired at an average cost of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the transaction, the chief executive officer now owns 14,743,907 shares in the company, valued at $12,090,003.74. This trade represents a 0.49 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders purchased a total of 179,649 shares of company stock worth $143,163 over the last three months. 54.60% of the stock is owned by insiders.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent quarter. Hedge funds and other institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.